T. Maher (London, United Kingdom), M. Romagnoli (Forli, Italy)
Prevalence of interstitial lung disease (ILD) in a lung cancer screening program using low-dose computer tomography (CT)
M. Sánchez-Carpintero Abad, L. Seijo Maceiras, M. Ferreira, M. Uxua, A. Ana Belén, C. Aranzazu, J. P. De Torres, P. Jesús, B. Gorka, Z. F. Javier (Pamplona, Spain)
|    |
Physiology is a better predictor of mortality than HRTC findings in patients with fibrotic idiopathic interstitial pneumonia
F. Novelli, L. Tavanti, F. Martino, S. Cini, L. Melosini, C. Romei, F. Falaschi, S. Solfanelli, A. Celi, P. Paggiaro (Pisa, Italy)
| |
Six-minute-walk test: Desaturation index in diffuse parenchymal lung disease
D. Visca, A. De Lauretis, G. Pasciuto, G. Gioffrè, S. Andrea, R. Inchingolo, F. Macagno, G. M. Corbo, S. Valente (Rome, Italy)
| |
Abnormal pulmonary arterial remodelling in patients with combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF)
E. Balestro, F. Lunardi, E. Rossi, N. Nannini, G. Marulli, M. Loy, F. Rea, F. Calabrese (Padova, Italy)
| |
Outcome of patients with interstitial lung disease admitted into ICU
A. Vial-Dupuy, O. Sanchez, L. Guetta, B. Douvry, K. Juvin, D. Wermert, E. Guerot, D. Israel-Biet (Paris, France)
| |
The King‘s brief interstitial lung disease quality of life questionnaire (K-BILD) for patients with IPF and other ILDs
A. S. Patel, R. Siegert, K. Brignall, S. Bhajwah, S. R. Desai, A. U. Wells, I. J. Higginson, S. S. Birring (London, United Kingdom)
| |
Demonstration of diagnostic and prognostic benefits of an interstitial lung disease (ILD) multidisciplinary team meeting
L. Spencer, S. Grundy, M. Greaves, P. Bishop, A. Duck, C. Leonard (Manchester, Liverpool, United Kingdom)
| |